Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Goldline

Executive Summary

Will market 12 SoloPak generic injectable drugs. The 12 products are: flurouracil, gentamicin sulfate, haloperidol, heparin, hydroxyzine, magnesium sulfate, metoclopramide, nitroglycerin, phenytoin, prochlorperazine edisylate, propranolol, and trimethobenzamide. Twenty-seven different SKUs are part of the deal, which will give Goldine a line of 71 injectable products. "We are committed to being a 'major player' in the institutional marketplace," Goldline said. Firm projects the injectables will generate $ 1 mil. in sales in first year.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019295

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel